Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Top Ten Advances in Hematology in China in 2023

Home » Top Ten Advances in Hematology in China in 2023
Tumor Cell-Released Kynurenine Biases MEP Differentiation into Megakaryocytes in Individuals with Cancer: A Novel Mechanism for Thrombocytosis and Erythrocytopenia

Tumor Cell-Released Kynurenine Biases MEP Differentiation into Megakaryocytes in Individuals with Cancer: A Novel Mechanism for Thrombocytosis and Erythrocytopenia

Posted by By Yin, Jiale 2024.01.22
In December 2023, a study led by Professor Bo Huang  and his team from the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, was published in the prestigious international…
Read More
Deciphering STING-Driven Platelet Activation in Septic Thrombosis: A Comprehensive Study Unveiling Molecular Mechanisms and Therapeutic Avenues

Deciphering STING-Driven Platelet Activation in Septic Thrombosis: A Comprehensive Study Unveiling Molecular Mechanisms and Therapeutic Avenues

Posted by By Yin, Jiale 2024.01.22
In May 2023, a study led by Professor JunLing Liu from the School of Medicine, Shanghai Jiao Tong University, was published in the prestigious international academic journal ——Immunity (IF=43.474). The research, titled "STING…
Read More
Single-Cell Dissection of Human Hematopoietic Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation

Single-Cell Dissection of Human Hematopoietic Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation

Posted by By Yin, Jiale 2024.01.22
In March 2023, a study led by the team of Professor  Tao Cheng from the Blood Disease Hospital of the Chinese Academy of Medical Sciences (Institute of Hematology, Chinese Academy of…
Read More
The Complexity of Diffuse Large B-Cell Lymphoma: A Revolutionary Genetic Subtyping Algorithm

The Complexity of Diffuse Large B-Cell Lymphoma: A Revolutionary Genetic Subtyping Algorithm

Posted by By Yin, Jiale 2024.01.22
In April 2023, a retrospective study led by Professor WeiLi Zhao  from Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine was published in the prestigious international academic journal ——Signal Transduction and…
Read More
The Role of PD-1 Signaling in T-Cell Acute Lymphoblastic Leukemia: A Revolutionary Breakthrough

The Role of PD-1 Signaling in T-Cell Acute Lymphoblastic Leukemia: A Revolutionary Breakthrough

Posted by By Yin, Jiale 2024.01.22
In January 2023, a  study led by Professor  Meng Zhao   from Zhongshan School of Medicine was published in the prestigious international academic journal ——Nature Cell Biology (IF=21.3). The title of the study is…
Read More
Advancing Precision Medicine in Diffuse Large B Cell Lymphoma: Insights from the GUIDANCE-01 Trial

Advancing Precision Medicine in Diffuse Large B Cell Lymphoma: Insights from the GUIDANCE-01 Trial

Posted by By Yin, Jiale 2024.01.22
In September 2023, a study led by Professor Weili Zhao   from Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, was published in the prestigious international academic journal ——Cancer Cell (IF=38.585). The…
Read More
The Pan-Cancer Dynamics of Natural Killer Cells: Insights into Heterogeneity and Dysfunction

The Pan-Cancer Dynamics of Natural Killer Cells: Insights into Heterogeneity and Dysfunction

Posted by By Yin, Jiale 2024.01.22
In September 2023, a study led by Professor Zemin Zhang  from Peking University  was published in the prestigious international academic journal ——Cell (IF=64.5). The title of the study is "A pan-cancer single-cell…
Read More
Recent Posts
  • ESMO China Voice | Professor Jiesong Wang: The iPET-NCCN-IPI Model May Optimize Risk Stratification in Diffuse Large B-Cell Lymphoma
  • ESMO China Voice | Dr. Sicong Zhang: Refractory DLBCL Patients Share Similar Immune Signatures
  • ESMO China Voice | Dr. Cong Sun: Grade 3B Follicular Lymphoma Is an Independent Risk Factor Affecting Both PFS and OS
  • ESMO China Voice | Prof. Liang Wang: CD19/CD22 Bispecific CAR-T Therapy Demonstrates Remarkable Efficacy and Safety in R/R LBCL
  • 13th FACO Annual Academic Conference Grandly Held in Shanghai! Leading Experts from China, Japan, and South Korea Gather to Foster Clinical Oncology
Recent Comments
    Archives
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Media Medic Publishing Company Limited(HK)
    赛美出版有限公司(香港)
    Scroll to Top